Sodium Sulfate, Potassium Sulfate, Magnesium Sulfate Solution
NDC Package 40032-700-83

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Sodium Sulfate, Potassium Sulfate, Magnesium Sulfate solution is classified as a

administered via oral route. This formulation utilizes a solution delivery system. Marketed by Novel Laboratories, Inc., this product is identified by NDC 40032-700 and is authorized under FDA application ANDA202511.

Identification & Billing

NDC Package Code
40032-700-83
Package Description
2 BOTTLE in 1 CARTON / 177 mL in 1 BOTTLE
Product Code
40032-700
11-Digit Billing Format
40032070083
RxNorm Crosswalk
  • RxCUI: 1001689 - {2 (480 ML) (magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution) } Pack
  • RxCUI: 1001689 - 2 (16 OZ magnesium sulfate 1.6 GM / potassium sulfate 3.13 GM / sodium sulfate 17.5 GM Oral Solution) Pack
  • RxCUI: 1120068 - magnesium sulfate 1.6 GM / potassium sulfate 3.13 GM / sodium sulfate 17.5 GM in 177 mL Oral Solution
  • RxCUI: 1120068 - magnesium sulfate 0.0277 MEQ/ML / potassium sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution
  • RxCUI: 1120068 - Magnesium Sulfate 0.0277 MEQ/ML / K+ sulfate 0.0374 MEQ/ML / sodium sulfate 0.257 MEQ/ML Oral Solution

Clinical Specifications

Proprietary Name
Sodium Sulfate, Potassium Sulfate, Magnesium Sulfate
Non-Proprietary Name
Sodium Sulfate, Potassium Sulfate, Magnesium Sulfate
Substance Name
Magnesium Sulfate Anhydrous; Potassium Sulfate; Sodium Sulfate
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Novel Laboratories, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA202511
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-23-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 40032-700-83 identifies a specific commercial package of 2 bottle in 1 carton / 177 ml in 1 bottle of Sodium Sulfate, Potassium Sulfate, Magnesium Sulfate, a human prescription drug labeled by Novel Laboratories, Inc.. This solution is formulated for oral use and contains magnesium sulfate anhydrous; potassium sulfate; sodium sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Novel Laboratories, Inc. on February 23, 2017. The current certification is valid through December 31, 2026.

How is this Novel Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 40032070083. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
40032-700-83
11-Digit CMS (5-4-2)
40032-0700-83

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.